DG Capital Management (Massachusetts)’s Bristol-Myers Squibb BMY Stock Holding History

DG Capital Management (Massachusetts)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-34,196	Closed	-$2.52M	–	63
2016 Q2	$2.52M	Sell	34,196 -7,345	-18%	-$519K	2.68%	10
2016 Q1	$2.65M	Sell	41,541 -7,020	-14%	-$443K	2.6%	11
2015 Q4	$3.34M	Sell	48,561 -3,134	-6%	-$207K	2.98%	9
2015 Q3	$3.06M	Sell	51,695 -12,210	-19%	-$775K	2.06%	15
2015 Q2	$4.25M	Buy	63,905 +24,330	+61%	+$1.6M	2.56%	6
2015 Q1	$2.55M	Buy	+39,575	New	+$2.48M	1.54%	29

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

DG Capital Management (Massachusetts)'s BMY Position: Q3 2016 in Review

DG Capital Management (Massachusetts) sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 34,196 shares — an estimated $2.52M sold.

DG Capital Management (Massachusetts) first reported a position in BMY in Q1 2015 and held it in 6 quarters. The position peaked at $4.25M in Q2 2015. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

DG Capital Management (Massachusetts) reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
DG Capital Management (Massachusetts) sold 34,196 Bristol-Myers Squibb shares in Q3 2016, an estimated $2.52M.
DG Capital Management (Massachusetts) first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 6 quarters.
DG Capital Management (Massachusetts)'s Bristol-Myers Squibb position peaked at $4.25M in Q2 2015.
1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2016, filed 21 Oct 2016.